NCT00425334View on ClinicalTrials.gov

Safety Study of Hemospan® in Prostatectomy Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

November 30, 2007

Conditions

Blood Loss, SurgicalProstate CancerSurgery

Interventions

DRUG

Hemospan (MP4OX)

250 mL or 500 mL Hemospan (MP4OX)

DRUG

Ringer's lactate

250 mL or 500 mL Ringer's lactate USP

Trial Locations (1)

21287

Johns Hopkins Medical Institutions, Baltimore

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sangart

INDUSTRY